Addex Pharmaceuticals (SWISS: ADXN) announced that based on preliminary review of the unblinded data from study 206, it has terminated development of ADX10059 for chronic indications, including long term treatment of gastroesophageal reflux disease and migraine prophylaxis…

Read about new research findings that suggest video game users learn to process information faster and more accurately when they're playing in virtual worlds and in real-life situations on RxList.com

Learn about a new scientists report that claims carrots may be good for the eyes, but so are leafy green vegetables and colored fruits on RxList.com

Read about how Americans are taking action and getting vaccinated against the H1N1 swine flu on RxList.com

Learn about the FDA's reverse statement about the link between use of the cholesterol-lowering drug Vytorin and cancer on RxList.com